½ÃÀ庸°í¼­
»óǰÄÚµå
1807949

¼¼°èÀÇ È¯ÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå ¿¹Ãø : Á¦Ç° À¯Çüº°, À¯Åë ä³Îº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°(2025-2030³â)

Patient Temperature Monitoring Market by Product Type, Distribution Channel, Application, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀåÀÇ 2024³â ½ÃÀå ±Ô¸ð´Â 22¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025³â¿¡´Â 23¾ï 3,000¸¸ ´Þ·¯, CAGR 6.19%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 31¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ 2024³â 22¾ï ´Þ·¯
ÃßÁ¤ ¿¬µµ 2025³â 23¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ 2030³â 31¾ï 6,000¸¸ ´Þ·¯
CAGR(%) 6.19%

ÀÓ»ó °á°ú Çâ»ó ¹× ¼¼°è ¹Ì·¡ ÀÇ·á Àü·« Çü¼º¿¡¼­ ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ±â¼úÀÇ Áß¿äÇÑ ¿ªÇÒÀ» ±Ô¸í

ȯÀÚ ÄɾîÀÇ Á¤È®¼º°ú Áï°¢¼ºÀ» ¾çº¸ÇÒ ¼ö ¾ø´Â ½Ã´ë¿¡ À־, ü¿Â ÃøÁ¤Àº ÀÏ»óÀûÀΠüũ·ÎºÎÅÍ Á¤±³ÇÑ ÀÓ»ó»óÀÇ Çʼö »çÇ×À¸·Î ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ¼¾¼­ÀÇ ¼ÒÇüÈ­¿Í µðÁöÅÐ ¿¬°áÀÇ Áøº¸·Î °£´ÜÇÑ Ã¼¿Â ÃøÁ¤Àº ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ÅëÇÕ ±¸¼º ¿ä¼Ò·Î º¯¸ðÇß½À´Ï´Ù. º´¿ø, Ŭ¸®´Ð, ȨÄɾî Á¦°ø¾÷ü, ½ÇÇè½Ç¿¡¼­´Â ÈÞ´ë¿ë ±â±â¿Í ¿þ¾î·¯ºí ±â±â ¸ðµÎ¸¦ »ç¿ëÇÏ¿© ½Ç½Ã°£ µ¥ÀÌÅ͸¦ ¾ò´Â °æÇâÀÌ °­ÇØÁ® ¹ß¿­ »óÅÂÀÇ Á¶±â ¹ß°ß°ú ½Å¼ÓÇÑ °³ÀÔÀÌ °¡´ÉÇØÁö°í ÀÖ½À´Ï´Ù.

¼¼°èÀûÀÎ ±Þ¼ÓÇÑ ±â¼ú Áøº¸¿Í ÁøÈ­ÇÏ´Â ÀÓ»ó ÆÐ·¯´ÙÀÓ Áß È¯ÀÚÀÇ Ã¼¿Â ¸ð´ÏÅ͸µÀÇ º¯È­ÀûÀÎ º¯È­¸¦ ÃßÀû

Áö³­ 10³â°£ ¼¾¼­ÀÇ Á¤È®¼º°ú µ¥ÀÌÅÍ ÅëÇÕÀÇ È¹±âÀûÀÎ Áøº¸·Î ȯÀÚÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ »óȲÀÌ ±ØÀûÀ¸·Î º¯È­Çß½À´Ï´Ù. µðÁöÅРü¿Â°è´Â ÀÓ»óÀǰ¡ ¼ø°£ÀûÀÎ ÃøÁ¤Ä¡¸¦ ¿ä±¸ÇÏ°Ô µÇ¾ú°í, ºñÁ¢ÃË Àû¿Ü¼± ¼Ö·ç¼ÇÀº °¨¿° Á¦¾îÀÇ ¿ì·Á¿¡ ´ëÀÀÇß½À´Ï´Ù. µ¿½Ã¿¡ ÀÇ·á±â±â Á¦Á¶¿¡¼­ Áö¼Ó°¡´É¼ºÀ» ¿ä±¸ÇÏ´Â ±¤¹üÀ§ÇÑ µ¿ÇâÀ» ¹Ý¿µÇÏ¿© ¾×ü¸¦ À¯¸®¿¡ ºÀÀÔÇÑ ±â±¸´Â º¸´Ù ź·ÂÀûÀ̰í ȯ°æÄ£È­ÀûÀÎ ´ëüǰÀ¸·Î ±× ÀÚ¸®¸¦ ¾çµµÇß½À´Ï´Ù.

2025³â ¹Ì±¹ °ü¼¼ ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå, °ø±Þ¸Á, ¼¼°è °æÀï ±¸µµ¿¡ ´ëÇÑ ´©Àû ¿µÇâ °ËÁõ

2025³â ¹Ì±¹ °ü¼¼ µµÀÔÀº ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ÀåºñÀÇ Á¶´Þ°ú À¯Åë¿¡ »õ·Î¿î ¿ªÇÐÀ» µµÀÔÇß½À´Ï´Ù. Á¦Á¶¾÷ü°¡ ºñ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ°í ´ëü Á¶´Þ Àü·«À» ¸ð»öÇÏ´Â µ¿¾È °ø±Þ¸ÁÀº ÀçÁ¶Á¤ÇؾßÇÕ´Ï´Ù. ¼öÀÔ ¼¾¼­ ºÎǰ¿¡ ´ëÇÑ °ü¼¼ ¾Ð·ÂÀº Á¦Á¶ ºñ¿ë°ú ÃÖÁ¾ »ç¿ëÀÚ¸¦ À§ÇÑ ÀåºñÀÇ °¡Ä¡°¨°úÀÇ ±ÕÇüÀ» ¸ÂÃ߸鼭 °ø±Þ¾÷ü ³×Æ®¿öÅ©ÀÇ ´Ù¾çÈ­¸¦ ±â¾÷¿¡ Ã˱¸Çϰí ÀÖ½À´Ï´Ù.

ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç ½ÃÀå ¿ªÇаú ¼ÒºñÀÚ ¼±È£µµ¸¦ ¹àÈ÷´Â ÁÖ¿ä ¼¼ºÐÈ­ ÅëÂû·Â

ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µÀÇ Á¦Ç° Ä«Å×°í¸®¸¦ ºÐ¼®Çϸé ÈÞ´ë¿ëÇü°ú ¿þ¾î·¯ºíÇüÀ» ¸ðµÎ Æ÷ÇÔÇÑ µðÁöÅРü¿Â°è´Â ½Å¼ÓÇÑ ÀÀ´ä ½Ã°£°ú ¿¬°á ±â´ÉÀ¸·Î Çö´ë ÀÓ»ó ¿öÅ©Ç÷οìÀÇ Áß½ÉÀÌ µÇ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. À̸¶³ª °í¸·¿¡ ÀåÂøÇÏ´Â À¯ÇüÀÇ Àû¿Ü¼± ü¿Â°è´Â °Å¸®°¡ ¸¹Àº °÷¿¡¼­ÀÇ ¾ö°ÝÇÑ À§»ý ÇÁ·ÎÅäÄÝ¿¡ ÀûÇÕÇÑ ºñÁ¢ÃË ÃøÁ¤ÀÌ °¡´ÉÇÕ´Ï´Ù. ÇÑÆí, ±âÁ¸ÀÇ À¯¸® ¾×»ó °èÃø±â´Â °£Æí¼º°ú Àúºñ¿ëÀÌ ÃÖ¿ì¼±ÀûÀÎ Æ´»õ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖÀ¸¸ç, ½ÅÈïÀÇ Á¦·Î ¿­À¯¼Ó ½Ã½ºÅÛÀº Ä¡¸íŸ °ü¸® ½Ã³ª¸®¿À¿¡¼­ Áö¼ÓÀûÀÎ ÇÙ½É Ã¼¿Â ÃßÀûÀ» À§ÇÑ ÁöÁö¸¦ ¸ðÀ¸°í ÀÖ½À´Ï´Ù.

ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µÀÇ Áö¸®Àû ÃËÁø¿äÀÎ, »õ·Î¿î µ¿Çâ, ¼ºÀå ±âȸ¸¦ ÀÌÇØÇϱâÀ§ÇÑ ÁÖ¿ä Áö¿ª ÅëÂû·Â ÆÄ¾Ç

Áö¿ªº° ºÐ¼®¿¡ µû¸£¸é, ¾Æ¸Þ¸®Ä«´Â °í±Þ ÀÇ·á ÀÎÇÁ¶ó¿Í À¯¸®ÇÑ »óȯ Á¤Ã¥ÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖÀ¸¸ç, ÃÖ÷´Ü ü¿Â ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ ±Þ¼ÓÇÑ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ºÏ¹ÌÀÇ ÀÇ·á Á¦°ø¾÷ü´Â µðÁöÅÐ ¹× ¿þ¾î·¯ºí Àåºñ¸¦ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ³ë·Â¿¡ ÅëÇÕÇϰí ÀÖÀ¸¸ç, ¶óƾ¾Æ¸Þ¸®Ä«¿¡¼­´Â ¹Î°£ Çù·ÂÀ» È®´ëÇÏ¿© ºñ¿ë È¿À²ÀûÀÎ Àåºñ¿¡ ´ëÇÑ ¾×¼¼½º¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù.

ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ¾÷°èÀÇ Çõ½Å, Àü·«Àû Çù¾÷ ¹× °æÀï ¿ªÇÐÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ

ÁÖ¿ä ±â¾÷Àº Â÷¼¼´ë ü¿Â ¸ð´ÏÅ͸µ ÀåºñÀÇ µµÀÔÀ» À§ÇØ ¿¬±¸ °³¹ß ³ë·ÂÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ¸ÞµåÆ®·Î´ÐÀº ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ »ýŰè¿Í ¿øÈ°ÇÏ°Ô ÅëÇյǴ ¹«¼± ¼­¹Ì½ºÅÍ Ç÷§ÆûÀ» °³¹ßÇß½À´Ï´Ù. Omron Healthcare´Â ºí·çÅõ½º ¿¬°áÀ» ÅëÇÕÇÏ¿© ¿ø°Ý ÀÇ·á ¿ëµµ¸¦ Áö¿øÇÏ´Â ÈÞ´ë¿ë µðÁöÅÐ Á¦Ç°À» °è¼Ó ¿¬¸¶Çϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡, Hill-RomÀº Áß¿äÇÑ Ä¡·á ȯ°æ¿¡¼­ Áö¼ÓÀûÀÌ°í ºñħ½ÀÀûÀÎ ¸öÅë ¿Âµµ ÃøÁ¤À» °¡´ÉÇÏ°Ô ÇÏ´Â Á¦·Î ¿­À¯¼Ó ±â¼úÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù.

»õ·Î¿î ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ±âȸ¸¦ Ȱ¿ëÇϰí Àü·«Àû À§ÇèÀ» ¿ÏÈ­Çϱâ À§ÇØ ¾÷°è ¸®´õµé¿¡°Ô ½ÇÇà °¡´ÉÇÑ Á¦¾È

¾÷°è ¸®´õ´Â ±âÁ¸ Á¦Ç° ¶óÀο¡ °í±Þ ¿¬°á ±â´ÉÀ» ÅëÇÕÇÏ¿© ¿ø°Ý ÀÇ·á Ç÷§Æû°ú ÀüÀÚ ÀÇ·á ±â·ÏÀ» ÅëÇØ ü¿Â µ¥ÀÌÅ͸¦ ¿øÈ°ÇÏ°Ô °øÀ¯ÇÒ ¼ö ÀÖµµ·Ï ÇØ¾ß ÇÕ´Ï´Ù. ¿þ¾î·¯ºí ±â¼ú°ú ºñÁ¢ÃË ±â¼ú¿¡ ÅõÀÚÇÔÀ¸·Î½á ƯÈ÷ ÀçÅÃÄ¡·á ¹× ¿Ü·¡ ȯÀÚ¿¡¼­ ȯÀÚÀÇ Æí¾ÈÇÔ°ú °¨¿° ÅëÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ÒÇÁÆ®¿þ¾î Á¦°ø¾÷ü¿Í Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ¿¬°áÇÏ¿© ºÎ°¡°¡Ä¡ ºÐ¼® ¼­ºñ½º¸¦ »ý¼ºÇÏ°í ¿ø½Ã µ¥ÀÌÅ͸¦ ½Ç¿ëÀûÀÎ ÀÓ»ó ÅëÂû·ÂÀ¸·Î ÀüȯÇÒ ¼ö ÀÖ½À´Ï´Ù.

ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå ¿ªÇÐÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Áö¿øÇÏ´Â ¾ö°ÝÇÑ Á¶»ç ±â¹ý°ú µ¥ÀÌÅÍ °ËÁõ ÇÁ·Î¼¼½º¿¡ ´ëÇØ ÀÚ¼¼È÷ ¾Ë¾Æº¸½Ê½Ã¿À.

ÀÌ ¼³¹®Á¶»ç´Â Á¾ÇÕÀûÀÎ 2Â÷ ¼³¹®Á¶»ç¿Í ¸ñÇ¥·Î »ïÀº 1Â÷ ¼³¹® Á¶»çÀÇ µÎ °¡Áö Á¢±Ù ¹æ½ÄÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù. ¾÷°è ÃâÆÇ¹°, ±ÔÁ¦ ´ç±¹¿¡ÀÇ ½Å°í, °ËÅä ÇмúÁö¸¦ ü°èÀûÀ¸·Î °ËÅäÇÏ¿© ±â±â ±â¼ú°ú ÀÓ»ó ÀÀ¿ë¿¡ °üÇÑ ±âÃÊÀûÀÎ ÀÌÇØ¸¦ ±í°Ô Çß½À´Ï´Ù. µ¿½Ã¿¡ ÀÇ·á Àü¹®°¡, Á¶´Þ Àü¹®°¡ ¹× Àåºñ Á¦Á¶¾÷ü¿ÍÀÇ ¸é¹ÐÇÑ ÀÎÅͺ並 ÅëÇØ ºñÁî´Ï½º °úÁ¦¿Í ä¿ë ÃËÁø¿äÀο¡ ´ëÇÑ ¹Ì¹¦ÇÑ °üÁ¡À» Á¦°øÇß½À´Ï´Ù.

ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ±â¼ú°ú ½ÃÀå ¹ßÀüÀÇ Àü·«Àû °úÁ¦¿Í ¹Ì·¡ÀÇ ±ËÀû¿¡ ´ëÇÑ °á·Ð

¿ä¾à : ȯÀÚÀÇ Ã¼¿Â ¸ð´ÏÅ͸µÀº ±â¼úÀûÀ¸·Î Á¤±³ÇÑ ºÐ¾ß·Î ÀüȯÇϰí ÀÖÀ¸¸ç, ¿©±â¿¡´Â µðÁöÅÐ ¿¬°á, ¼¾¼­ Çõ½Å, ±ÔÁ¦ ´ç±¹ÀÇ Áö¿øÀÌ °áÇյǾî ÀÓ»ó Áø·á¸¦ À籸¼ºÇϰí ÀÖ½À´Ï´Ù. ¼öµ¿ À¯¸® ¿Âµµ°è¿¡¼­ ÅëÇÕ µðÁöÅÐ ¹× Á¦·Î ¿­À¯¼Ó Ç÷§ÆûÀ¸·ÎÀÇ »ê¾÷ ¹ßÀü´Â Áø´Ü Á¤È®µµ¿Í ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â È®°íÇÑ Çå½ÅÀ» ¹Ý¿µÇÕ´Ï´Ù. Áö¿ª°ú °ü¼¼¿Í °ü·ÃµÈ °úÁ¦´Â °ø±Þ¸ÁÀÇ ÀçÆíÀ» ÃËÁøÇϰí ȸº¹·Â°ú ÇöÁö »ý»ê ´É·ÂÀ» ¸ðµÎ Ű¿ì°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ¿ªÇÐ

  • ÁýÁßÄ¡·á ¹× ÀÀ±ÞÄ¡·á¿¡ À־ÀÇ ÀÚµ¿ ü¿Â ÃßÀûÀÇ ÀÓ»ó ¿ä±¸ °íÁ¶
  • ½Ç½Ã°£ ü¿Â °¨½Ã¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â ½º¸¶Æ® ¿þ¾î·¯ºí ¼¾¼­ÀÇ Ã¤ÅÃ
  • ¿ø°Ý ¿Âµµ Æò°¡¸¦ Áö¿øÇÏ´Â ÅëÇÕ °¨½Ã Ç÷§ÆûÀÇ µµÀÔ
  • ü¿ÂÀÇ µ¿ÇâÀ¸·ÎºÎÅÍ °¨¿°ÀÇ Ãʱâ ¡Èĸ¦ ƯÁ¤Çϱâ À§ÇÑ µðÁöÅÐ Çコ ÅøÀÇ È®Àå
  • ü¿Â°èÀÇ Á¤¹Ðµµ¿Í ÀÀ´ä¼ºÀ» Çâ»ó½ÃŰ´Â ¼¾¼­ ±â¼úÀÇ Áøº¸
  • ¸¸¼º Áúȯ °ü¸®¿¡ À־ÀÇ Ã¼¿Â °¨½Ã¸¦ À§ÇÑ Ä¿³ØÆ¼µå Çコ ½Ã½ºÅÛÀÇ È°¿ë
  • Áö¼ÓÀûÀÎ ¿Âµµ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ÀÇÇÑ Àû±ØÀûÀÎ ¼ö¼ú ÈÄ Äɾî·ÎÀÇ Àüȯ
  • ȯÀÚÀÇ Ã¼¿Â º¯È­¸¦ ÇØ¼®Çϱâ À§ÇÑ ¿¹Ãø ºÐ¼®ÀÇ ±¸Çö
  • ¼Ò¾ÆÀÇ ¾ÈÀü¼ºÀ» Áß½ÃÇØ, À¯¾ÆÀÇ Ã¼¿Â ÃßÀû¿¡ À־ÀÇ Çõ½ÅÀ» ÃßÁø
  • ºñÁ¢ÃËÇü ü¿Â ÃøÁ¤À¸·ÎÀÇ ÀÌÇà¿¡ ÀÇÇØ ÀÓ»ó ¿öÅ©Ç÷ο쿡 À־ÀÇ À§»ý°ú ȯÀÚÀÇ ÄèÀû¼ºÀÌ Çâ»ó

Á¦6Àå ½ÃÀå ÀλçÀÌÆ®

  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦7Àå ¹Ì±¹ °ü¼¼ÀÇ ´©Àû ¿µÇâ 2025

Á¦8Àå ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : Á¦Ç° À¯Çüº°

  • µðÁöÅРü¿Â°è
    • ÈÞ´ë¿ë µðÁöÅРü¿Â°è
    • ¿þ¾î·¯ºí µðÁöÅРü¿Â°è
  • Àû¿Ü¼± ü¿Â°è
    • À̸¶ Àû¿Ü¼± ü¿Â°è
    • °í¸· Àû¿Ü¼± ü¿Â°è
  • À¯¸®°ü³» ¾×üü¿Â°è
  • Á¦·Î ¿­À¯¼Ó ü¿Â°è

Á¦9Àå ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : À¯Åë ä³Îº°

  • ¿ÀÇÁ¶óÀÎ
    • °Ç°­ ¹× À£´Ï½º ½ºÅä¾î
    • Àü¹®Á¡
    • ½´ÆÛ¸¶ÄÏ ¹× ÇÏÀÌÆÛ¸¶ÄÏ
  • ¿Â¶óÀÎ
    • ±â¾÷ À¥»çÀÌÆ®
    • ÀüÀÚ»ó°Å·¡ Ç÷§Æû

Á¦10Àå ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : ¿ëµµº°

  • ¸¶Ãë
  • ¼öÇ÷
  • Àúü¿ÂÁõ
  • ¹ß¿­

Á¦11Àå ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Ŭ¸®´Ð
  • ÀçÅà Äɾî
  • º´¿ø
  • ¿¬±¸±â°ü

Á¦12Àå ¾Æ¸Þ¸®Ä«ÀÇ È¯ÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå

  • ¹Ì±¹
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ȯÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå

  • ¿µ±¹
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ·¯½Ã¾Æ
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • µ§¸¶Å©
  • ³×´ú¶õµå
  • īŸ¸£
  • Çɶõµå
  • ½º¿þµ§
  • ³ªÀÌÁö¸®¾Æ
  • ÀÌÁýÆ®
  • Æ¢¸£Å°¿¹
  • À̽º¶ó¿¤
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • ½ºÀ§½º

Á¦14Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ È¯ÀÚ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå

  • Áß±¹
  • Àεµ
  • ÀϺ»
  • È£ÁÖ
  • Çѱ¹
  • Àεµ³×½Ã¾Æ
  • ű¹
  • Çʸ®ÇÉ
  • ¸»·¹À̽þÆ
  • ½Ì°¡Æ÷¸£
  • º£Æ®³²
  • ´ë¸¸

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2024
  • °æÀï ºÐ¼®
    • 3M Company
    • A&D Co., Ltd.
    • American Diagnostic Corporation
    • Becton, Dickinson and Company
    • Beurer GmbH
    • Cardinal Health Inc.
    • Cosinuss GmbH
    • Medisana GmbH
    • Microlife Corporation
    • DeltaTrak
    • Dragerwerk AG & Co. KGaA
    • Exergen Corporation
    • Geratherm Medical AG
    • Hill-Rom Holdings, Inc. by Baxter International Inc.
    • Kinsa Inc. by Healthy Together
    • Koninklijke Philips NV
    • Masimo Corp.
    • iHealth Labs Inc
    • Medtronic PLC
    • Nureca Ltd.
    • Dwyer Instruments, LLC
    • Omron Healthcare Inc.
    • Paul Hartmann AG
    • Terumo Corporation
    • SteadySense GmbH
    • VivaLNK, Inc.

Á¦16Àå ¸®¼­Ä¡ AI

Á¦17Àå ¸®¼­Ä¡ Åë°è

Á¦18Àå ¸®¼­Ä¡ ÄÁÅÃ

Á¦19Àå ¸®¼­Ä¡ ±â»ç

Á¦20Àå ºÎ·Ï

SHW 25.09.22

The Patient Temperature Monitoring Market was valued at USD 2.20 billion in 2024 and is projected to grow to USD 2.33 billion in 2025, with a CAGR of 6.19%, reaching USD 3.16 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.20 billion
Estimated Year [2025] USD 2.33 billion
Forecast Year [2030] USD 3.16 billion
CAGR (%) 6.19%

Unveiling the Critical Role of Patient Temperature Monitoring Technologies in Enhancing Clinical Outcomes and Shaping Future Healthcare Strategies Globally

In an era where precision and immediacy in patient care are non-negotiable, the measurement of body temperature has evolved from a routine check to a sophisticated clinical imperative. Advances in sensor miniaturization and digital connectivity have transformed simple thermometry into an integrated component of patient monitoring systems. Hospitals, clinics, homecare providers, and research laboratories are increasingly relying on both handheld and wearable devices to capture real-time data, enabling early detection of febrile conditions and rapid intervention.

Moreover, the convergence of artificial intelligence algorithms with smart sensors is enhancing the interpretation of temperature trends, offering predictive insights that can help avert complications. Transitioning beyond traditional mercury-based instruments, the industry now embraces a diverse array of devices capable of noninvasive assessment, reflecting a broader shift towards patient-centric care.

As remote patient monitoring gains regulatory endorsement and reimbursement frameworks expand, the demand for reliable thermometric solutions is surging. Telehealth platforms now integrate temperature sensors to enable caregivers to monitor individuals in homecare settings, marking a transition from episodic checks to continuous surveillance. This shift underscores the necessity for devices that deliver both accuracy and ease of use, ensuring that temperature readings are seamlessly incorporated into electronic health records.

Tracking Transformative Shifts in Patient Temperature Monitoring Amidst Rapid Technological Advancements and Evolving Clinical Paradigms Worldwide

Over the past decade, the landscape of patient temperature monitoring has shifted dramatically, driven by breakthroughs in sensor accuracy and data integration. Digital thermometers have gained prominence as clinicians demand instantaneous readings, while noncontact infrared solutions have addressed infection control concerns. Concurrently, liquid-in-glass instruments have ceded ground to more resilient and environmentally sound alternatives, reflecting a broader trend toward sustainability in medical device manufacturing.

In parallel, emerging technologies such as zero heat flux sensors are redefining the parameters of clinical measurement, offering continuous and noninvasive monitoring that aligns with the growing emphasis on patient comfort. As healthcare delivery models evolve, these innovations are being adopted in critical care, surgical suites, and even ambulatory settings, illustrating a migration from point-in-time assessments to longitudinal surveillance. Consequently, providers are equipped with richer datasets to inform diagnostic decisions, enhance perioperative management, and optimize therapeutic interventions, demonstrating how technological maturation is reshaping the face of thermometry.

Examining the Cumulative Impact of 2025 United States Tariffs on Patient Temperature Monitoring Markets, Supply Chains, and Global Competitive Landscapes

The introduction of United States tariffs in 2025 has introduced new dynamics into the procurement and distribution of patient temperature monitoring devices. Supply chains are experiencing recalibrations as manufacturers assess cost implications and explore alternative sourcing strategies. Tariff pressures on imported sensor components have prompted firms to diversify their supplier networks, balancing the trade-off between production costs and device affordability for end users.

Moreover, regional manufacturing hubs have gained strategic importance as companies evaluate nearshoring options to mitigate trade-related uncertainties. This realignment is fostering investment in local production capabilities and in-country assembly, which enhances resilience against policy fluctuations. In turn, healthcare providers are benefiting from more stable supply pipelines, though the short-term impact on device pricing has necessitated careful budgeting. As organizations adapt, collaboration between industry stakeholders and regulatory bodies is proving essential to streamline customs procedures and ensure that patient care remains uninterrupted.

Revealing Key Segmentation Insights to Illuminate Market Dynamics and Consumer Preferences in Patient Temperature Monitoring Solutions

Analysis of patient temperature monitoring product categories reveals that digital thermometers, encompassing both handheld and wearable formats, have become central to modern clinical workflows due to their rapid response times and connectivity features. Infrared options, with dedicated forehead and tympanic devices, deliver noncontact measurements that align with stringent hygiene protocols in high-traffic settings. Meanwhile, traditional liquid-in-glass instruments retain a niche role where simplicity and low cost are paramount, and emerging zero heat flux systems are gaining traction for continuous core temperature tracking in critical care scenarios.

Distribution pathways also illustrate evolving preferences among end users. Offline channels such as health and wellness stores, specialty medical outlets, and supermarkets and hypermarkets continue to serve a broad base of professional and consumer buyers, while online platforms-including manufacturer websites and major e-commerce marketplaces-are capturing growth by offering streamlined procurement and value-added digital services. Across clinical applications ranging from anesthesia management, blood transfusion monitoring, hypothermia prevention, to fever screening, devices are tailored to meet the precise requirements of clinics, homecare environments, hospitals, and research institutions, underscoring the importance of segmentation in driving product development and market positioning.

Capturing Key Regional Insights to Understand Geographic Drivers, Emerging Trends, and Growth Opportunities in Patient Temperature Monitoring

Regional analysis highlights that the Americas benefit from advanced healthcare infrastructures and favorable reimbursement policies, which encourage rapid adoption of state-of-the-art temperature monitoring solutions. North American providers have integrated digital and wearable devices into remote patient monitoring initiatives, while in Latin America, expanding public-private collaborations are strengthening access to cost-effective instruments.

In Europe, Middle East, and African territories, diverse regulatory landscapes and variable infrastructure maturity are shaping distinct adoption patterns. Western Europe is witnessing significant uptake of zero heat flux and infrared technologies driven by clinical guidelines, whereas emerging markets in the Middle East are investing in smart hospital projects that include integrated thermometry systems. Meanwhile, segments of Africa are prioritizing durable and easy-to-use handheld devices to support community health programs. Across Asia-Pacific, rising healthcare expenditures and a growing focus on telemedicine have fueled demand for connected wearable thermometers, particularly in urban centers, while cost sensitivity in developing markets underscores the ongoing relevance of liquid-in-glass and entry-level digital instruments.

Profiling Leading Companies Driving Innovation, Strategic Collaboration, and Competitive Dynamics in the Patient Temperature Monitoring Industry

Major players are intensifying their R&D efforts to introduce next-generation temperature monitoring devices. Medtronic has advanced wireless thermistor platforms that seamlessly integrate with remote patient monitoring ecosystems. Omron Healthcare continues to refine its handheld digital offerings, incorporating Bluetooth connectivity to support telehealth applications. At the same time, Hill-Rom is exploring zero heat flux technologies to enable continuous and noninvasive core temperature measurements in critical care environments.

In addition, Terumo Corporation is leveraging sensor miniaturization to develop compact infrared devices that cater to both pediatric and adult populations. Dragerwerk AG is collaborating with clinical institutions to validate innovative forehead band sensors that can transmit real-time data to centralized monitoring systems. Through strategic partnerships, patent filings, and targeted acquisitions, these companies are shaping competitive dynamics, driving down device costs, and expanding their foothold across diverse clinical and consumer settings.

Formulating Actionable Recommendations for Industry Leaders to Capitalize on Emerging Patient Temperature Monitoring Opportunities and Mitigate Strategic Risks

Industry leaders should prioritize the integration of advanced connectivity features into existing product lines, ensuring that temperature data can be seamlessly shared across telemedicine platforms and electronic health records. Investing in wearable and noncontact technologies will address growing demands for patient comfort and infection control, particularly in homecare and outpatient settings. Additionally, forging strategic partnerships with software providers can create value-added analytics services, transforming raw data into actionable clinical insights.

At the same time, manufacturers need to strengthen their supply chains by diversifying component sources and exploring localized assembly options, thereby mitigating exposure to tariff volatility. Engaging proactively with regulatory agencies and payer networks will expedite reimbursement pathways, while targeted pilot programs with key hospital systems can validate new device functionalities. By balancing innovation with operational resilience, industry stakeholders can capture emerging opportunities and sustain long-term growth.

Detailing Rigorous Research Methodology and Data Validation Processes Underpinning Comprehensive Analysis of Patient Temperature Monitoring Market Dynamics

This research draws upon a dual approach of comprehensive secondary research and targeted primary engagements. Industry publications, regulatory filings, and peer-reviewed journals were systematically reviewed to establish a foundational understanding of device technologies and clinical applications. Concurrently, in-depth interviews with healthcare professionals, procurement specialists, and device manufacturers provided nuanced perspectives on operational challenges and adoption drivers.

Data validation was conducted through cross-referencing supplier declarations, distribution channel analyses, and real-world case studies. Charting supply chain configurations and tariff mechanisms ensured that geopolitical factors were fully integrated into the assessment. The methodology also incorporated triangulation of qualitative insights and quantitative findings to uphold analytical rigor, delivering a well-substantiated overview of patient temperature monitoring market dynamics.

Concluding Reflections on Strategic Imperatives and Future Trajectories in Patient Temperature Monitoring Technologies and Market Evolution

In summary, patient temperature monitoring has transitioned into a technologically sophisticated field, where digital connectivity, sensor innovation, and regulatory support intersect to reshape clinical practice. The industry's evolution from manual glass thermometers to integrated digital and zero heat flux platforms reflects a steadfast commitment to improving diagnostic accuracy and patient outcomes. Regional and tariff-related challenges have prompted supply chain realignment, fostering both resilience and local production capabilities.

Looking ahead, the convergence of wearable sensors, AI-driven analytics, and telehealth integration will define the next wave of competitive differentiation. Stakeholders who embrace segmentation insights, fortify distribution networks, and engage strategically with payers and regulators will be best positioned to thrive. Ultimately, the imperative to deliver reliable, patient-friendly temperature solutions remains paramount, guiding future innovation and market development.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growing clinical need for automated temperature tracking in intensive and emergency care
  • 5.2. Adoption of smart wearable sensors enabling real time body temperature surveillance
  • 5.3. Deployment of integrated monitoring platforms supporting remote temperature assessment
  • 5.4. Expansion of digital health tools to identify early signs of infection through temperature trends
  • 5.5. Advancements in sensor technology improving accuracy and responsiveness of temperature devices
  • 5.6. Utilization of connected health systems to monitor temperature in chronic illness management
  • 5.7. Shift toward proactive post surgical care through continuous thermal monitoring solutions
  • 5.8. Implementation of predictive analytics to interpret patient temperature fluctuations
  • 5.9. Emphasis on pediatric safety driving innovation in temperature tracking for infants and children
  • 5.10. Transition to contactless thermometry enhancing hygiene and patient comfort in clinical workflows

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Patient Temperature Monitoring Market, by Product Type

  • 8.1. Introduction
  • 8.2. Digital Thermometers
    • 8.2.1. Handheld Digital Thermometers
    • 8.2.2. Wearable Digital Thermometers
  • 8.3. Infrared Thermometers
    • 8.3.1. Forehead Infrared Thermometers
    • 8.3.2. Tympanic Infrared Thermometers
  • 8.4. Liquid-In-Glass Thermometers
  • 8.5. Zero Heat Flux Thermometers

9. Patient Temperature Monitoring Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
    • 9.2.1. Health & Wellness Stores
    • 9.2.2. Specialty Stores
    • 9.2.3. Supermarkets/Hypermarkets
  • 9.3. Online
    • 9.3.1. Company Websites
    • 9.3.2. E-commerce Platforms

10. Patient Temperature Monitoring Market, by Application

  • 10.1. Introduction
  • 10.2. Anesthesia
  • 10.3. Blood Transfusion
  • 10.4. Hypothermia
  • 10.5. Pyrexia/Fever

11. Patient Temperature Monitoring Market, by End User

  • 11.1. Introduction
  • 11.2. Clinics
  • 11.3. Homecare
  • 11.4. Hospitals
  • 11.5. Research Institutions

12. Americas Patient Temperature Monitoring Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Patient Temperature Monitoring Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Patient Temperature Monitoring Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. 3M Company
    • 15.3.2. A&D Co., Ltd.
    • 15.3.3. American Diagnostic Corporation
    • 15.3.4. Becton, Dickinson and Company
    • 15.3.5. Beurer GmbH
    • 15.3.6. Cardinal Health Inc.
    • 15.3.7. Cosinuss GmbH
    • 15.3.8. Medisana GmbH
    • 15.3.9. Microlife Corporation
    • 15.3.10. DeltaTrak
    • 15.3.11. Dragerwerk AG & Co. KGaA
    • 15.3.12. Exergen Corporation
    • 15.3.13. Geratherm Medical AG
    • 15.3.14. Hill-Rom Holdings, Inc. by Baxter International Inc.
    • 15.3.15. Kinsa Inc. by Healthy Together
    • 15.3.16. Koninklijke Philips N.V.
    • 15.3.17. Masimo Corp.
    • 15.3.18. iHealth Labs Inc
    • 15.3.19. Medtronic PLC
    • 15.3.20. Nureca Ltd.
    • 15.3.21. Dwyer Instruments, LLC
    • 15.3.22. Omron Healthcare Inc.
    • 15.3.23. Paul Hartmann AG
    • 15.3.24. Terumo Corporation
    • 15.3.25. SteadySense GmbH
    • 15.3.26. VivaLNK, Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦